Plasma neurofilament light for early differentiation of multiple system atrophy from Parkinson disease
Zhenwei Yu, Yuanchu Zheng, Wenyi Kou, Huihui Cai, Siming Li, Jiayi Wu, Chen Yang, Bingxu Zhu, Genliang Liu, Yuke Wang, Hao Tian, Xinning Zhang, Ying Zhou, Xuedong Liu, Ying Chang, Zhigang Chen, Wei Mao, Tao Feng · 2026
Read Plasma neurofilament light for early differentiation of multiple system atrophy from Parkinson disease by Zhenwei Yu, Yuanchu Zheng, Wenyi Kou, Huihui Cai, Siming Li, Jiayi Wu, Chen Yang, Bingxu Zhu, Genliang Liu, Yuke Wang, Hao Tian, Xinning Zhang, Ying Zhou, Xuedong Liu, Ying Chang, Zhigang Chen, Wei Mao, Tao Feng (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13560527.txt.
Description
Two brain illnesses can look alike in their first years: one moves toward stiff, slow motion, the other brings early falls, eye trouble, and fast decline. Zhenwei Yu and co-authors test a blood marker in a 2026 study that may split the two sooner. The marker is a thread protein freed when nerve fibers break down, and it can be read from a simple blood draw.
More than two thousand people took part across five centers in China, split into a test group and a later check group. The marker alone split the two illnesses well, and it held up in people sick for under two years. Adding three more markers helped little. The team backs a marker-first path for clinics, since a firm early call shapes care plans and trial entry.
Catalog record
| CREATOR | Zhenwei Yu, Yuanchu Zheng, Wenyi Kou, Huihui Cai, Siming Li, Jiayi Wu, Chen Yang, Bingxu Zhu, Genliang Liu, Yuke Wang, Hao Tian, Xinning Zhang, Ying Zhou, Xuedong Liu, Ying Chang, Zhigang Chen, Wei Mao, Tao Feng |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 44 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |